Patricio Ledesma

Patricio Ledesma serves as Chief Executive Officer at Sofpromed Clinical Research, LLC. Sofpromed Clinical Research, LLC operates in the pharmaceuticals sector with approximately 35.0 employees.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 Google Analytics Nginx WordPress.org Google Tag Manager YouTube Mobile Friendly Basis

ensayos clinicos & cro pharmaceutical manufacturing clinical trials cro electronic data capture edc systems biostatistics data management regulatory affairs drug safety monitoring site feasibility medical writing clinical research biotechnology project management data validation statistics pharmacovigilance formulation development api manufacturing clinical trial logistics fsp early phase trials phase i phase ii phase iii phase iv oncology gynecologic cancers cardiovascular studies metabolic diseases cns diseases dermatology respiratory diseases infectious diseases pain management sarcomas drug labeling drug packaging sample size calculation gxp compliance data integration study design community-based research ethics submissions clinical trial quote safety reports protocol development randomization bioanalysis pharmaceuticals medical health care health wellness & fitness hospital & health care productivity enterprise software enterprises computer software information technology & services b2b

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Patricio Ledesma in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Sofpromed Clinical Research, LLC.

Patricio Ledesma's Position in the MessageCEO Database

• •Patricio Ledesma is 1 of 1 verified executive contact we track at Sofpromed Clinical Research, LLC.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •14 verified contacts work at pharmaceuticals companies in the 35.0 employee range (same size as Sofpromed Clinical Research, LLC).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Patricio Ledesma directly?

Patricio Ledesma's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Sofpromed Clinical Research, LLC. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Patricio Ledesma work for?

Patricio Ledesma is Chief Executive Officer at Sofpromed Clinical Research, LLC, a company in the pharmaceuticals sector with 35.0 employees.

Can I pitch or sell to Patricio Ledesma?

As Chief Executive Officer at Sofpromed Clinical Research, LLC, Patricio Ledesma is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Patricio Ledesma directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Patricio Ledesma in?

Patricio Ledesma works in the pharmaceuticals industry as Chief Executive Officer at Sofpromed Clinical Research, LLC. MessageCEO provides verified contact information for executives across all major industries.

Is Patricio Ledesma's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Patricio Ledesma's profile is kept up-to-date with the latest available information.

Last updated: June 23, 2026